191
TITLE: EFFECTS OF KETOTIFEN ON MAMMRY TUMORS VOLUME AND WEIGHT
AUTHORS: Ana I Faustino Rocha; Carla Pinto; Adelina Gama; Paula A Oliveira;
PUBLISHED: 2014, SOURCE: ANTICANCER RESEARCH, VOLUME: 34, ISSUE: 10
INDEXED IN: WOS
IN MY: ORCID
192
TITLE: CARBOPLATIN AND PIROXICAM EFFECTS ON HUMAN URINARY BLADDER CANCER CELL LINES
AUTHORS: Jessica Silva; Rosario Pinto Leite; Ana I Faustino Rocha; Aura Colaco; Regina Arantes Rodrigues; Paula A Oliveira;
PUBLISHED: 2014, SOURCE: ANTICANCER RESEARCH, VOLUME: 34, ISSUE: 10
INDEXED IN: WOS
IN MY: ORCID
195
TITLE: Implementation of humane endpoints on bladder cancer research
AUTHORS: Oliveira, MCC; Faustino Rocha, AI; Vala, H; Oliveira, PA;
PUBLISHED: 2014, SOURCE: VIRCHOWS ARCHIV, VOLUME: 465
INDEXED IN: WOS Handle
IN MY: ORCID
196
TITLE: Effects of intense pulsed light on skin carcinogenesis
AUTHORS: Faustino Rocha, AI; Gama, A; Rodrigues, D; Colaco, B; Vala, H; Pires, MJ; Oliveira, PA;
PUBLISHED: 2014, SOURCE: VIRCHOWS ARCHIV, VOLUME: 465
INDEXED IN: WOS Handle
IN MY: ORCID
197
TITLE: Histological classification of urothelial lesions chemically-induced in the male rat model
AUTHORS: Faustino Rocha, AI; Pinto, C; Vala, H ; Ferreira, R; Oliveira, PA;
PUBLISHED: 2014, SOURCE: VIRCHOWS ARCHIV, VOLUME: 465
INDEXED IN: WOS Handle
IN MY: ORCID
198
TITLE: Re: Establishment of novel rat models for premalignant breast disease
AUTHORS: Faustino Rocha, AI; Oliveira, PA; Colaco, B; Alvarado, A;
PUBLISHED: 2014, SOURCE: CHINESE MEDICAL JOURNAL, VOLUME: 127, ISSUE: 24
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
200
TITLE: Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer
AUTHORS: Rosário Pinto-Leite; Isabel Carreira; Joana Melo; Susana Isabel Ferreira; Ilda Ribeiro; Jaqueline Ferreira; Marco Filipe; Carina Bernardo; Regina Arantes-Rodrigues; Paula Oliveira; Lúcio Santos;
PUBLISHED: 2014, SOURCE: Tumor Biol. - Tumor Biology, VOLUME: 35, ISSUE: 5
INDEXED IN: CrossRef: 29
IN MY: ORCID
Page 20 of 25. Total results: 249.